Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7459)
All Articles published online
|
Publishing Process of This Article
|
Oct 28, 2016 (publication date) through Nov 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Kliemann DA, Tovo CV, da Veiga ABG, de Mattos AA, Wood C. Polymorphisms and resistance mutations of hepatitis C virus on sequences in the European hepatitis C virus database. World J Gastroenterol 2016; 22(40): 8910-8917 [PMID: 27833382 DOI: 10.3748/wjg.v22.i40.8910] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v22/i40/8910.htm |
| Number | Citing Articles |
| 1 |
Sorin Dinu, Grațiela Țârdei, Emanoil Ceaușu, Simin Aysel Florescu, Laurențiu Micu, Alina Monica Ecobici, Mariana Mihăilă, Gabriela Oprișan. Detection of anti-protease inhibitors resistance mutations in HCV strains infecting treatment-naïve chronic patients from Romania. Revista Romana de Medicina de Laborator 2018; 26(4): 443 doi: 10.2478/rrlm-2018-0029
|
| 2 |
Figen Sarıgul, Murat Sayan, Ulku User, Nefise Oztoprak. Evaluation of Direct Acting Antivirals Efficiency in Turkish Patients with Chronic Hepatitis C Under Strict Rules. Hepatitis Monthly 2019; (In Press) doi: 10.5812/hepatmon.62390
|
| 3 |
Zhenqiu Liu, Xianhua Mao, Jiaqi Wu, Kangkang Yu, Qin Yang, Chen Suo, Ming Lu, Li Jin, Tiejun Zhang, Xingdong Chen. World-wide Prevalence of Substitutions in HCV Genome Associated With Resistance to Direct-Acting Antiviral Agents. Clinical Gastroenterology and Hepatology 2021; 19(9): 1906 doi: 10.1016/j.cgh.2019.10.046
|
| 4 |
Desirée Lopes da Silva, Heloisa Marceliano Nunes, Pedro Eduardo Bonfim Freitas. Natural prevalence of NS3 gene resistance-associated substitutions (RASs) in patients with chronic hepatitis C from the state of Pará/Brazil. Virus Research 2021; 292: 198251 doi: 10.1016/j.virusres.2020.198251
|
| 5 |
Abdulrazzaq N. Zghair, Nazar Sh. Mohammed, Sumayah Faruq Kasim. Gene Sequencing of Hepatitis C Virus Isolated from Patients with Liver Diseases. Journal of Pure and Applied Microbiology 2023; 17(2): 819 doi: 10.22207/JPAM.17.2.08
|
| 6 |
Alfredo P. Martínez, Andrés C.A. Culasso, Paula S. Pérez, Vanesa Romano, Rodolfo H. Campos, Ezequiel Ridruejo, Gabriel García, Federico A. Di Lello. Polymorphisms associated with resistance to protease inhibitors in naïve patients infected with hepatitis C virus genotype 1 in Argentina: Low prevalence of Q80K. Virus Research 2017; 240: 140 doi: 10.1016/j.virusres.2017.08.006
|
| 7 |
Victor de Lédinghen, Clovis Lusivika‐Nzinga, Jean‐Pierre Bronowicki, Fabien Zoulim, Dominique Larrey, Sophie Metivier, Albert Tran, Patrick Marcellin, Didier Samuel, Olivier Chazouillères, Stephane Chevaliez, Celine Dorival, Hélène Fontaine, Jean‐Michel Pawlotsky, Fabrice Carrat, Stanislas Pol. Sofosbuvir‐Daclatasvir is suboptimal in patients with genotype 2 chronic hepatitis C infection: real‐life experience from the HEPATHER ANRS CO22 cohort. Journal of Viral Hepatitis 2020; 27(10): 964 doi: 10.1111/jvh.13321
|
| 8 |
Ana Elisa de Figueiredo Miranda Mundim, Fernanda de Oliveira Feitosa de de Castro, Marina Brandão Braz Albuquerque, Cesar Augusto Sam Tiago Vilanova-Costa, Irmtraut Araci Hoffmann Pfrimer, Antonio Márcio Teodoro Cordeiro Silva. Major mutations in the NS3 gene region of hepatitis C virus related to the resistance to direct acting antiviral drugs: a systematic review. VirusDisease 2020; 31(3): 220 doi: 10.1007/s13337-020-00616-9
|
| 9 |
Will Gelson, Graeme Alexander. Is elimination of hepatitis C from the UK by 2030 a realistic goal?. British Medical Bulletin 2017; 123(1): 59 doi: 10.1093/bmb/ldx017
|
| 10 |
Zhe Jiao, Yuanyuan Yan, Yixi Chen, Gang Wang, Xiaowei Wang, Lisha Li, Mengfang Yang, Xiaoshuai Hu, Yilin Guo, Yuejun Shi, Guiqing Peng, Tom Gallagher. Adaptive Mutation in the Main Protease Cleavage Site of Feline Coronavirus Renders the Virus More Resistant to Main Protease Inhibitors. Journal of Virology 2022; 96(17) doi: 10.1128/jvi.00907-22
|
| 11 |
Jianjun Gao, Chuanxia Ju. Research progress on the direct antiviral drugs for hepatitis C virus. BioScience Trends 2017; 11(1): 41 doi: 10.5582/bst.2016.01266
|
| 12 |
Pooneh Rahimi, Heidar Sharafi, Golnaz Bahramali, FaridehSadat SajadianFard, Nafiseh Sadat Asadi, Seyed Moayed Alavian, Vahid Iranpur Mobarakeh, Seyedeh Zahra Moravej. Prevalence of Naturally-Occurring NS5A and NS5B Resistance-Associated Substitutions in Iranian Patients With Chronic Hepatitis C Infection. Frontiers in Microbiology 2021; 11 doi: 10.3389/fmicb.2020.617375
|
| 13 |
Ahmed Emam, Khaled R. A. Abdellatif, Noha H. Amin, Khaled M. Elokely. HCV NS5B RdRp mutations and their effects on ligand binding affinity. International Journal of Modelling and Simulation 2022; 42(3): 415 doi: 10.1080/02286203.2021.1923953
|
| 14 |
V A Malov, E A Ubeeva, I P Ubeeva, S M Nikolaev, K T Umbetova. Treatment of chronic viral hepatitis C with direct acting antiviral agent: review. Terapevticheskii arkhiv 2019; 91(11): 86 doi: 10.26442/00403660.2019.11.000307
|
| 15 |
Philippe Halfon, Caroline Scholtès, Jacques Izopet, Sylvie Larrat, Pascale Trimoulet, Fabien Zoulim, Laurent Alric, Sophie Métivier, Vincent Leroy, Denis Ouzan, Victor De Lédinghen, Sofane Mohamed, Guillaume Pénaranda, Hacène Khiri, Marie-Ange Thélu, Anne Plauzolles, Laurent Chiche, Marc Bourlière, Florence Abravanel. Baseline and Post-Treatment Hepatitis C NS5A Resistance in Relapsed Patients from a Multicentric Real-Life Cohort. Antiviral Therapy 2018; 23(4): 307 doi: 10.3851/IMP3184
|
| 16 |
Song Yang, Huichun Xing, Shenghu Feng, Wei Ju, Shunai Liu, Xiaomei Wang, Weini Ou, Jun Cheng, Calvin Q. Pan. Prevalence of NS5B resistance-associated variants in treatment-naïve Asian patients with chronic hepatitis C. Archives of Virology 2018; 163(2): 467 doi: 10.1007/s00705-017-3640-6
|
| 17 |
Lei Dai, Yushen Du, Hangfei Qi, Christian D. Huber, Dongdong Chen, Tian-Hao Zhang, Nicholas C. Wu, Ergang Wang, James O. Lloyd-Smith, Ren Sun, Tiffany A. Reese. Quantifying the Evolutionary Constraints and Potential of Hepatitis C Virus NS5A Protein. mSystems 2021; 6(2) doi: 10.1128/msystems.01111-20
|
| 18 |
Michael Hermann Wißing, Toni Luise Meister, Maximilian Klaus Nocke, André Gömer, Mejrema Masovic, Leonard Knegendorf, Yannick Brüggemann, Verian Bader, Anindya Siddharta, Claus-Thomas Bock, Alexander Ploss, Scott P. Kenney, Konstanze F. Winklhofer, Patrick Behrendt, Heiner Wedemeyer, Eike Steinmann, Daniel Todt. Genetic determinants of host- and virus-derived insertions for hepatitis E virus replication. Nature Communications 2024; 15(1) doi: 10.1038/s41467-024-49219-8
|
| 19 |
Itzíar Carrasco, Ana Arias, Laura Benítez‐Gutiérrez, Gemma Lledó, Silvia Requena, Miriam Cuesta, Valentín Cuervas‐Mons, Carmen de Mendoza. Baseline NS5A resistance associated substitutions may impair DAA response in real‐world hepatitis C patients. Journal of Medical Virology 2018; 90(3): 532 doi: 10.1002/jmv.24971
|
| 20 |
Lucio Boglione, Simone Mornese Pinna, Tommaso Lupia, Giuseppe Cariti, Giovanni Di Perri1. Retreatment with Sofosbuvir/Velpatasvir in Cirrhotic Patients with Genotype-4 who Failed a Previous Interferon-Free Regimen: A Case Series. Antiviral Therapy 2018; 23(6): 543 doi: 10.3851/IMP3226
|
| 21 |
Calvin Q. Pan, Benjamin C. Tiongson, Ke-Qin Hu, Steven-Huy B. Han, Myron Tong, Danny Chu, James Park, Tai Ping Lee, Kalyan Ram Bhamidimarri, Xiaoli Ma, Pei Ying Xiao, Smruti R. Mohanty, Dan Wang. Real-World Study on Sofosbuvir-based Therapies in Asian Americans With Chronic Hepatitis C. Journal of Clinical Gastroenterology 2019; 53(2): 147 doi: 10.1097/MCG.0000000000001078
|
| 22 |
Gül R. Yilmaz, Christoph Boesecke, Carolynne Schwarze‐Zander, Jürgen K. Rockstroh. Hepatitis C reinfection with protease inhibitor‐resistant hepatitis C virus in an HIV‐coinfected MSM. Liver International 2020; 40(1): 47 doi: 10.1111/liv.14275
|
| 23 |
Dong Xiao, Xing Dai, Hong Liu, Shuwen He, Zhi-Cai Shi, Steven W. Ludmerer, Fangbiao Li, Ravi Nargund, Anandan Palani. Multi-step parallel synthesis enabled optimization of benzofuran derivatives as pan-genotypic non-nucleoside inhibitors of HCV NS5B. Bioorganic & Medicinal Chemistry Letters 2020; 30(7): 127004 doi: 10.1016/j.bmcl.2020.127004
|
| 24 |
Radwa R. El-Tahan, Ahmed M. Ghoneim, Hosam Zaghloul. Dissection of two drug-targeted regions of Hepatitis C virus subtype 4a infecting Egyptian patients. Virus Genes 2020; 56(5): 564 doi: 10.1007/s11262-020-01776-y
|